Arcus Biosciences, Inc. (RCUS)
23.60
-1.54
(-6.11%)
USD |
NYSE |
Dec 12, 10:45
Arcus Biosciences Research and Development Expense (TTM): 503.00M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Actinium Pharmaceuticals, Inc. | 20.82M |
| Apyx Medical Corp. | 3.546M |
| Gilead Sciences, Inc. | 5.734B |
| Merck & Co., Inc. | 14.26B |
| Karyopharm Therapeutics, Inc. | 130.89M |